The Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial: Rationale for Its Methodology and a Review of the Effectiveness of Switching Antipsychotics. Academic Article

Overview

abstract

(Reprinted with permission from Schizophrenia Bulletin 2015; 41(3):549-558).

authors

Rossum, Inge Winter-van

Fleischhacker, Walter
Glenthøj, Birte
Leboyer, Marion
Leweke, F Markus
Lewis, Shôn
McGuire, Phillip
Meyer-Lindenberg, Andreas
Rujescu, Dan
Kapur, Shitij
Kahn, René S
Sommer, Iris E

publication date

July 8, 2016

published in

Focus (American Psychiatric Publishing) Journal

Identity

PubMed Central ID

PMC6526795

Digital Object Identifier (DOI)

10.1176/appi.focus.140302

PubMed ID

31997959

Additional Document Info

volume

14

issue

3